ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 148 filers reported holding ACORDA THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $46,000 | -56.6% | 66,100 | -68.1% | 0.00% | – |
| Q3 2020 | $106,000 | +58.2% | 206,968 | +124.2% | 0.00% | – |
| Q2 2020 | $67,000 | -56.8% | 92,320 | -44.6% | 0.00% | – |
| Q1 2020 | $155,000 | -21.3% | 166,625 | +72.3% | 0.00% | – |
| Q4 2019 | $197,000 | +99.0% | 96,684 | +181.1% | 0.00% | – |
| Q3 2019 | $99,000 | -96.9% | 34,400 | -91.8% | 0.00% | -100.0% |
| Q2 2019 | $3,223,000 | -45.2% | 420,273 | -5.1% | 0.00% | -50.0% |
| Q1 2019 | $5,885,000 | +6.7% | 442,803 | +25.1% | 0.00% | 0.0% |
| Q4 2018 | $5,513,000 | +81.7% | 353,842 | +129.2% | 0.00% | 0.0% |
| Q3 2018 | $3,034,000 | -21.1% | 154,400 | +15.3% | 0.00% | 0.0% |
| Q2 2018 | $3,843,000 | +330.8% | 133,900 | +255.2% | 0.00% | – |
| Q1 2018 | $892,000 | +63.1% | 37,700 | +47.8% | 0.00% | – |
| Q4 2017 | $547,000 | -59.2% | 25,500 | -55.0% | 0.00% | -100.0% |
| Q3 2017 | $1,341,000 | -93.2% | 56,707 | -94.4% | 0.00% | -94.1% |
| Q2 2017 | $19,820,000 | +111.3% | 1,006,094 | +125.2% | 0.02% | +112.5% |
| Q1 2017 | $9,379,000 | +374.6% | 446,672 | +325.1% | 0.01% | +166.7% |
| Q4 2016 | $1,976,000 | -84.4% | 105,079 | -82.7% | 0.00% | -75.0% |
| Q3 2016 | $12,697,000 | +303.1% | 608,105 | +392.3% | 0.01% | +200.0% |
| Q2 2016 | $3,150,000 | +385.4% | 123,511 | +403.2% | 0.00% | +300.0% |
| Q1 2016 | $649,000 | +310.8% | 24,546 | +564.8% | 0.00% | – |
| Q4 2015 | $158,000 | -64.9% | 3,692 | -78.3% | 0.00% | – |
| Q3 2015 | $450,000 | -29.5% | 16,994 | -11.2% | 0.00% | -100.0% |
| Q1 2015 | $638,000 | +8.9% | 19,144 | +33.4% | 0.00% | 0.0% |
| Q4 2014 | $586,000 | -83.5% | 14,346 | -86.3% | 0.00% | -75.0% |
| Q3 2014 | $3,557,000 | -86.4% | 105,009 | -86.5% | 0.00% | -86.7% |
| Q2 2014 | $26,228,000 | +225.6% | 778,038 | +266.1% | 0.03% | +233.3% |
| Q1 2014 | $8,056,000 | -8.7% | 212,521 | -29.7% | 0.01% | -18.2% |
| Q4 2013 | $8,828,000 | +153.0% | 302,334 | +197.0% | 0.01% | +120.0% |
| Q3 2013 | $3,490,000 | +104.9% | 101,787 | +97.2% | 0.01% | +66.7% |
| Q2 2013 | $1,703,000 | – | 51,627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |